HIM
PFE icon

Hillsdale Investment Management’s Pfizer PFE Stock Holding History

Hillsdale Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83K Sell
2,955
-2,390
-45% -$63.6K ﹤0.01% 589
2025
Q4 		$133K Sell
5,345
-1,525
-22% -$38.5K ﹤0.01% 509
2025
Q3 		$175K Buy
6,870
+4,490
+189% +$111K 0.01% 490
2025
Q2 		$57.7K Hold
2,380
– – ﹤0.01% 484
2025
Q1 		$60.3K Sell
2,380
-43,715
-95% -$1.14M ﹤0.01% 465
2024
Q4 		$1.22M Buy
46,095
+40,750
+762% +$1.11M 0.06% 228
2024
Q3 		$155K Buy
+5,345
New +$156K 0.01% 420
2024
Q2 		– Sell
-3,132
Closed -$86.9K – 673
2024
Q1 		$86.9K Buy
3,132
+1,650
+111% +$45.8K 0.01% 434
2023
Q4 		$42.7K Sell
1,482
-70
-5% -$2.12K ﹤0.01% 432
2023
Q3 		$51.5K Sell
1,552
-972
-39% -$34.4K ﹤0.01% 423
2023
Q2 		$92.6K Sell
2,524
-455
-15% -$17.7K 0.01% 378
2023
Q1 		$122K Buy
2,979
+410
+16% +$17.7K 0.01% 443
2022
Q4 		$132K Sell
2,569
-11,000
-81% -$527K 0.01% 424
2022
Q3 		$593K Hold
13,569
– – 0.05% 274
2022
Q2 		$712K Sell
13,569
-2,711
-17% -$138K 0.06% 242
2022
Q1 		$842K Sell
16,280
-2,000
-11% -$104K 0.05% 273
2021
Q4 		$1.08M Sell
18,280
-720
-4% -$35.7K 0.07% 232
2021
Q3 		$817K Buy
19,000
+1,340
+8% +$59.4K 0.06% 291
2021
Q2 		$691K Buy
17,660
+16,510
+1,436% +$642K 0.06% 307
2021
Q1 		$42K Sell
1,150
-230
-17% -$8.17K ﹤0.01% 470
2020
Q4 		$50K Sell
1,380
-3,405
-71% -$125K ﹤0.01% 438
2020
Q3 		$166K Buy
4,785
+558
+13% +$19.6K 0.02% 397
2020
Q2 		$132K Sell
4,227
-11,910
-74% -$405K 0.01% 402
2020
Q1 		$501K Sell
16,137
-2,508
-13% -$85.5K 0.06% 293
2019
Q4 		$693K Buy
18,645
+18,381
+6,963% +$655K 0.06% 293
2019
Q3 		$9K Sell
264
-2,645
-91% -$96.2K ﹤0.01% 501
2019
Q2 		$119K Sell
2,909
-980
-25% -$38.9K 0.01% 405
2019
Q1 		$157K Sell
3,889
-10,287
-73% -$412K 0.01% 391
2018
Q4 		$586K Sell
14,176
-738
-5% -$30.6K 0.07% 173
2018
Q3 		$624K Sell
14,914
-8,864
-37% -$341K 0.08% 155
2018
Q2 		$818K Buy
23,778
+10,698
+82% +$366K 0.1% 166
2018
Q1 		$441K Sell
13,080
-95
-0.7% -$3.27K 0.06% 198
2017
Q4 		$454K Buy
13,175
+32
+0.2% +$1.09K 0.07% 210
2017
Q3 		$445K Buy
13,143
+11,583
+743% +$372K 0.08% 199
2017
Q2 		$50K Buy
1,560
+11
+0.7% +$347 0.01% 311
2017
Q1 		$50K Sell
1,549
-9,476
-86% -$299K 0.01% 304
2016
Q4 		$339K Sell
11,025
-42
-0.4% -$1.28K 0.07% 207
2016
Q3 		$355K Buy
11,067
+1,523
+16% +$50.9K 0.09% 226
2016
Q2 		$319K Buy
9,544
+9,159
+2,379% +$292K 0.09% 251
2016
Q1 		$11K Sell
385
-12,152
-97% -$347K ﹤0.01% 361
2015
Q4 		$384K Buy
12,537
+4,210
+51% +$132K 0.15% 156
2015
Q3 		$248K Sell
8,327
-1,686
-17% -$54.1K 0.08% 260
2015
Q2 		$319K Buy
10,013
+1,265
+14% +$41.2K 0.1% 223
2015
Q1 		$289K Buy
8,748
+2,002
+30% +$63.6K 0.07% 301
2014
Q4 		$199K Buy
6,746
+422
+7% +$12.1K 0.05% 327
2014
Q3 		$177K Sell
6,324
-9,697
-61% -$272K 0.06% 329
2014
Q2 		$451K Buy
16,021
+10,762
+205% +$307K 0.1% 110
2014
Q1 		$160K Sell
5,259
-3,057
-37% -$91.1K 0.04% 338
2013
Q4 		$242K Buy
8,316
+949
+13% +$27.6K 0.07% 275
2013
Q3 		$201K Hold
7,367
– – 0.06% 281
2013
Q2 		$196K Buy
+7,367
New +$204K 0.06% 298

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Hillsdale Investment Management's PFE Position: Q1 2026 in Review

Hillsdale Investment Management reduced its Pfizer (PFE) stake by 45% in Q1 2026, selling an estimated $63.6K and leaving 2,955 shares worth $83K. The position accounts for ﹤0.01% of the portfolio, ranked #589.

Hillsdale Investment Management first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.22M in Q4 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Hillsdale Investment Management held 2,955 shares of Pfizer worth $83K as of Q1 2026.
  • Hillsdale Investment Management sold 2,390 Pfizer shares in Q1 2026, an estimated $63.6K.
  • Pfizer made up ﹤0.01% of Hillsdale Investment Management's portfolio in Q1 2026, its #589 holding.
  • Hillsdale Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
  • Hillsdale Investment Management's Pfizer position peaked at $1.22M in Q4 2024.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.